UBS Initiates Coverage on Addus Homecare with Buy Rating, PT $145

UBS Initiates Coverage on Addus Homecare with Buy Rating, PT $145

UBS Group AG has initiated coverage on Addus Homecare Corporation (ADUS) with a buy rating and a price target of $145. The financial services firm's positive outlook comes as Addus Homecare Corp recently filed for a mixed shelf offering, with the size of the offering not disclosed [1].

Addus Homecare Corporation is engaged in providing home care services, with its segments including Personal Care, Hospice, and Home Health. The Personal Care segment offers non-medical assistance with activities of daily living, while the Hospice segment provides physical, emotional, and spiritual care for terminally ill individuals. The Home Health segment provides medical services to individuals requiring assistance during illness or after hospitalization [2].

UBS's price target of $145 suggests a bullish outlook on the company's future prospects, although the firm maintains a neutral rating on the stock. The rating reflects the firm's assessment of Addus Homecare's strong performance in the home care market and its recent strategic initiatives.

Investors should closely monitor Addus Homecare's financial performance and analyst ratings to make informed decisions. Despite the increased investment and positive outlook, the stock remains volatile, with a 12-month low of $2.75 and a 12-month high of $4.50 [3].

References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_FWN3UJ10D:0-addus-homecare-corp-files-for-mixed-shelf-size-not-disclosed/
[2] https://www.marketscreener.com/news/addus-homecare-corp-files-for-mixed-shelf-size-not-disclosed-ce7c50ded08df225
[3] https://www.ainvest.com/news/ubs-raises-petco-health-pt-3-7-maintains-neutral-rating-2508/